These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression. Israelyan N; Del Colle A; Li Z; Park Y; Xing A; Jacobsen JPR; Luna RA; Jensen DD; Madra M; Saurman V; Rahim R; Latorre R; Law K; Carson W; Bunnett NW; Caron MG; Margolis KG Gastroenterology; 2019 Aug; 157(2):507-521.e4. PubMed ID: 31071306 [TBL] [Abstract][Full Text] [Related]
3. The enteric nervous system is a potential autoimmune target in multiple sclerosis. Wunsch M; Jabari S; Voussen B; Enders M; Srinivasan S; Cossais F; Wedel T; Boettner M; Schwarz A; Weyer L; Göcer O; Schroeter M; Maeurer M; Woenckhaus M; Pollok K; Radbruch H; Klotz L; Scholz CJ; Nickel J; Friebe A; Addicks K; Ergün S; Lehmann PV; Kuerten S Acta Neuropathol; 2017 Aug; 134(2):281-295. PubMed ID: 28620692 [TBL] [Abstract][Full Text] [Related]
4. Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents. Kesidou E; Touloumi O; Lagoudaki R; Nousiopoulou E; Theotokis P; Poulatsidou KN; Boziki M; Kofidou E; Delivanoglou N; Minti F; Hadjigeorgiou G; Grigoriadis N; Simeonidou C J Neuroinflammation; 2017 Nov; 14(1):227. PubMed ID: 29162133 [TBL] [Abstract][Full Text] [Related]
5. Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Wang D; Bhat R; Sobel RA; Huang W; Wang LX; Olsson T; Steinman L Drug Dev Res; 2014 May; 75(3):172-88. PubMed ID: 24648292 [TBL] [Abstract][Full Text] [Related]
6. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
7. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice. Lin X; Liu Y; Ma L; Ma X; Shen L; Ma X; Chen Z; Chen H; Li D; Su Z; Chen X J Transl Med; 2021 Jul; 19(1):317. PubMed ID: 34301274 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson's disease mouse model. Li YH; Jiang ZX; Xu Q; Jin TT; Huang JF; Luan X; Li C; Chen XY; Wong KH; Dong XL; Sun XR Biomed Pharmacother; 2024 May; 174():116518. PubMed ID: 38565057 [TBL] [Abstract][Full Text] [Related]
9. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Anderson G; Noorian AR; Taylor G; Anitha M; Bernhard D; Srinivasan S; Greene JG Exp Neurol; 2007 Sep; 207(1):4-12. PubMed ID: 17586496 [TBL] [Abstract][Full Text] [Related]
10. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis. Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992 [TBL] [Abstract][Full Text] [Related]
11. Absence of system x Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920 [TBL] [Abstract][Full Text] [Related]
12. Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis. Ugarte-Berzal E; Berghmans N; Boon L; Martens E; Vandooren J; Cauwe B; Thijs G; Proost P; Van Damme J; Opdenakker G PLoS One; 2018; 13(10):e0197944. PubMed ID: 30273366 [TBL] [Abstract][Full Text] [Related]
13. A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. Ray A; Mann MK; Basu S; Dittel BN J Neuroimmunol; 2011 Jan; 230(1-2):1-9. PubMed ID: 21145597 [TBL] [Abstract][Full Text] [Related]